As IVIg alone is not sufficient to treat NF155+ CIDP and nerve hypertrophy responds poorly to immunotherapy after long disease duration (5), early introduction of combined therapy with corticosteroids and immunosuppressants is recommended. The gene discussed is PMP22; the disease is hypertrophy.